Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Learn how Yale's Phase I clinical trial program is revolutionizing patient care and advancing oncology research through this 25-minute conference presentation from Yale Cancer Center's Review of Advances in Oncology from the 2025 ASCO Annual Meeting. Discover the innovative approaches and methodologies employed by Yale's Phase I program that are directly impacting patient outcomes and contributing to breakthrough developments in cancer treatment. Explore the intersection of cutting-edge clinical research and practical patient care applications, examining how early-phase clinical trials are being designed and implemented to maximize both scientific advancement and therapeutic benefit for patients. Gain insights into the program's unique strategies for patient selection, trial design, and translational research that are setting new standards in oncology clinical development. Understand the broader implications of Phase I research on the future of cancer treatment and how academic medical centers are leading the charge in transforming experimental therapies into viable treatment options for patients with cancer.
